.
Nisentil, 1, 3, dimethyl-4-phenyl-4 him to regulate the duration and degree of propionoxy piperidine, was first syntheanaesthesia to suit the needs of the opera-sized by Lee in 1947 (Ziering and Lee, tion. For muscular relaxation, this degree 1947) and is structurally similar to pethiof controllability has already been met by dine (see figure 1) . the use of suxamethonium in continuous intravenous drip (Foldes, Machaj, Hunt and McNall, 1952; Foldes, McNall and Borrego-Hinojosa, 1952) . The idea of combining various anaesthetic agents was first suggested by Crile and Lower (1914) and Lundy (1926) . In recent years, various analgesic agents have been used in repeated small intravenous doses to supFio plement nitrous oxide-oxygen, thiopentone anaesthesia (Neff, Mayer and de Peralez, 1947; Brotman and Cullen, In both human (Gross, Holland and Schueler, 1948) and animal (Holland and 1949) . By using these analgesic supple- experiments no development ments satisfactory depth of anaesthesia of tolerance could be observed with Nisencan be provided by smaller quantities of til. Vomiting, nausea, pruritus and other thiopentone, resulting in earlier post-side effects were less frequently encounoperative recovery. Pethidine (meperidine) tered with Nisentil than with methor-phinan or morphine (Lee and Hasegawa, 1950; Lee and Pfeiffer, 1951) . Nisentil, like other analgesics, produces a hyperglycaemia which parallels its analgesic action in duration (Kimura and DeBoer, 1951; Kimura, DeBoer, Walts and Keith, 1951; DeBoer, Keith and Walts, 1952; Kimura, Keith and Foster, 1952) . The effects of an intravenously administered therapeutic dose last about 45 minutes (Floody, 1954) . The mechanism by which Nisentil is decomposed has not yet been clarified; it has been assumed that the liver plays an important role in this process.
So far, Nisentil has been primarily used for the production of analgesia in the first stage of labour (Hapke and Barnes, 1949; Smith and Nagyfy, 1949; Thelen, 1949; La Forge, 1951; Lund, 1951; Pfeiffer, 1951; Kane, 1953) . For this purpose, Nisentil was administered subcutaneously in 40-60 mg. doses to a total of over 2,000 cases. Satisfactory analgesia was obtained in 80-95 per cent of the parturients. Drowsiness and sedation were noted, but the patients were easily roused and mentally clear. Dizziness was the most frequently observed side effect.
MATERIAL AND METHODS
In the present study, Nisentil was used for the supplementation of nitrous oxideoxygen, thiopentone anaesthesia in 756 patients. In a control group of 600 patients pethidine was used as the supplementing agent. Both groups were further subdivided as follows: (1) patients who received no muscle relaxant; (2) patients who received relaxant for intubation only; (3) patients who received relaxants throughout anaesthesia (table I). 
Anaesthetic Management.
After the patient's mouth and pharynx had been sprayed with a topical anaesthetic agent enough thiopentone was administered to permit the insertion of an oropharyngeal airway. Nitrous oxideoxygen was then administered by the method of Foldes, Ceravolo and Carpenter (1952) and the first dose of Nisentil was given. The initial dose varied with the age, weight, physical condition and habits of the patient; the average was 7.5 mg. In old, weak, debilitated or heavily premedicated individuals and in patients with liver disease or hypothyroidism, the initial dose was decreased to 3.5 mg. Conversely, in large robust subjects, an initial dose of 12 to 15 mg. was used. The size of subsequent fractional doses varied according to the effects of the initial dose. Apart from the usual signs of lightening anaesthesia, an increase in the respiratory rate to over 20 per minute was considered an indication for the administration of a supplementary dose. The average interval between doses was 8 to 20 minutes. Occasionally, fractional doses had to be given more frequently early in the anaesthesia to obtain the desired depth. As the anaesthesia progressed fractional doses were required less frequently. After induction, no further thiopentone was given unless adequate anaesthesia, characterized by insensitivity to reflex stimulation originating in the operative area, could not be obtained without undue depression of the respiratory rate. In patients where muscle relaxants were used the first dose of Nisentil was administered, and its effects noted, before the relaxant was given.
Method of Evaluation.
Two criteria have been used in comparing the relative efficiency of Nisentil and pethidine for the supplementation of nitrous oxide-oxygen, thiopentone anaesthesia: (1) the mg./minute thiopentone dose used in operations of various durations; (2) the percentage of patients reacting to auditory and tactile stimulation within five minutes of the conclusion of surgery.
It RESULTS is evident from table IV that the mg./minute doses of thiopentone diminished progressively with increasing duration of anaesthesia. It will also be seen from this table that the mg./minute thiopentone requirements with Nisentil were significantly smaller than with pethidine. Pethidine is a longer-acting analgesic and is therefore more cumulative than Nisentil. The mg./minute doses of Nisentil and pethidine also diminished with increasing length of anaesthesia; this decrease, however, was more marked with pethidine than with Nisentil (table V). As would be expected, with the smaller quantities of thiopentone used, a greater percentage of patients reacted to stimulation at the termination of surgery in the Nisentil group than in the pethidine group (table  VI) .
It has been our impression that Nisentil had a greater effect on respiratory rate than depth. In contradistinction, pethidine seemed to have a more pronounced effect on the tidal volume than on the respiratory rate. Neither Nisentil nor pethidine had any consistent effect on pulse rate or blood pressure.
DISCUSSION
The analgesic agent used to supplement nitrous oxide-oxygen, thiopentone anaesthesia should be short-acting, have minimal cumulative effect and therefore be readily controllable. We have found that Nisentil, employed as described above, closely approaches these requirements. Using small doses of this agent it was possible to maintain satisfactory depths of general anaesthesia during surgery with less thiopentone than would otherwise have been used. Furthermore, the use of repeated small doses of Nisentil did not result in undue depression of respiration or other vital functions. In a few cases not included in this study Nisentil was used in larger doses to decrease further the thiopentone requirements. Marked slowing of • Includes all cases up to one hour. the respiratory rate, necessitating assisted respiration, was encountered in almost every case and, in contrast to our expectations, post-operative recovery was delayed rather than expedited.
A similar investigation with Nisentil was carried out independently by one of us in England; the results of this unpublished work correspond closely with our findings (Swerdlow, 1954) .
SUMMARY
(1) The use of small intravenous doses of Nisentil has been described for the supplementation of nitrous oxide-oxygen, thiopentone anaesthesia.
(2) The mg./minute dose of thiopentone required for operative procedures of various duration and the percentage of patients reacting to stimulation at the termination of surgery were compared in two series receiving Nisentil and pethidine respectively.
(3) The mg./minute dose of thiopentone was significantly lower with Nisentil than with pethidine supplementation.
(4) The percentage of patients reacting to stimulation at the termination of surgery was greater in the Nisentil than in the pethidine group.
(5) The use of Nisentil as a supplementary agent permitted increased controllability of the depth of anaesthesia without undue depression of respiration and other vital functions.
(6) The use of large doses of Nisentil resulted in respiratory depression and decreased controllability.
